Your browser doesn't support javascript.
loading
Utilidad del estudio PET con FDG en la evaluación de sarcomas de diverso origen y de tumores no sarcoma-no epiteliales / Positron emission tomography with fluorine-deoxyglucose in sarcomas and non-sarcoma non-epithelial tumors
Massardo, Teresa; Jofré, María Josefina; Sierralta, María Paulina; Canessa, José; Castro, Gabriel; Berrocal, Isabel; Gallegos, Iván.
Affiliation
  • Massardo, Teresa; Hospital Clínico Universidad de Chile. Departamento de Medicina. Sección Medicina Nuclear. CL
  • Jofré, María Josefina; Hospital Clínico Universidad de Chile. Departamento de Medicina. Sección Medicina Nuclear. CL
  • Sierralta, María Paulina; Hospital Clínico Universidad de Chile. Departamento de Medicina. Sección Medicina Nuclear. CL
  • Canessa, José; Hospital Clínico Universidad de Chile. Departamento de Medicina. Sección Medicina Nuclear. CL
  • Castro, Gabriel; Hospital Clínico Universidad de Chile. Departamento de Medicina. Sección Medicina Nuclear. CL
  • Berrocal, Isabel; Hospital Clínico Universidad de Chile. Departamento de Medicina. Sección Medicina Nuclear. CL
  • Gallegos, Iván; Hospital Clínico Universidad de Chile. Departamento de Medicina. Sección Medicina Nuclear. CL
Rev. méd. Chile ; 140(9): 1116-1125, set. 2012. ilus
Article de Es | LILACS | ID: lil-660068
Bibliothèque responsable: CL1.1
ABSTRACT

Background:

The usefulness of positron emission tomography (PET) with fluorine-deoxyglucose (FDG) in sarcomas and non-sarcoma non-epithelial (NSNE) tumors is not clearly defined.

Aim:

To report a Chilean experience with NSNE tumors evaluated using PET with FDG. Material and

Methods:

Retrospective review of the database of a PET laboratory. Demographic data, indications and metabolic findings were compared with conventional imaging in 88 adults and children with diverse bone and soft tissue sarcomas as well as 24 gastrointestinal stromal tumors (GIST), 6 pleural malignant mesotheliomas in adults, and 9 medulloblastomas in children.

Results:

FDG showed good concordance with conventional imaging in NSNE tumors. It was helpful for staging, restaging, follow-up after treatment and for the detection of new not previously suspected lesions.

Conclusions:

PET with FDG could have a prognostic role and help in patient management, mainly in musculos-keletal and high grade or less differentiated sarcomas. In GIST, it was a good tool for immunotherapy control.
Sujet(s)
Mots clés

Texte intégral: 1 Indice: LILACS Sujet Principal: Sarcomes / Radiopharmaceutiques / Tomographie par émission de positons / Tumeurs Type d'étude: Observational_studies / Prognostic_studies Limites du sujet: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male langue: Es Texte intégral: Rev. méd. Chile Thème du journal: MEDICINA Année: 2012 Type: Article

Texte intégral: 1 Indice: LILACS Sujet Principal: Sarcomes / Radiopharmaceutiques / Tomographie par émission de positons / Tumeurs Type d'étude: Observational_studies / Prognostic_studies Limites du sujet: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male langue: Es Texte intégral: Rev. méd. Chile Thème du journal: MEDICINA Année: 2012 Type: Article